Abstract
Cognitive deficit is a highly prevalent behavioral comorbidity in cancer patients. The inflammatory process underlying tumor development, in addition to influencing all stages of carcinogenesis, may contribute to the occurrence of cognitive impairment. Besides that, chemotherapy, such as paclitaxel (PCX), are agent that may favor behavioral comorbidities caused by its neurotoxic and neuro…